N-(1-naphthylmethyl)sulfamide

ID: ALA1088203

Cas Number: 877316-45-5

PubChem CID: 11550437

Max Phase: Preclinical

Molecular Formula: C11H12N2O2S

Molecular Weight: 236.30

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Synonyms: N-(1-Naphthylmethyl)Sulfamide | N-(1-naphthylmethyl)sulfamide|CHEMBL1088203|877316-45-5|1-[(sulfamoylamino)methyl]naphthalene|SCHEMBL4270510|BDBM50310429|N-[(naphthalen-1-yl)methyl]aminosulfonamide|EN300-273950|Z923953820

Canonical SMILES:  NS(=O)(=O)NCc1cccc2ccccc12

Standard InChI:  InChI=1S/C11H12N2O2S/c12-16(14,15)13-8-10-6-3-5-9-4-1-2-7-11(9)10/h1-7,13H,8H2,(H2,12,14,15)

Standard InChI Key:  REWBCXGLJQLNEO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
    3.5685  -19.4863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8577  -19.9012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8647  -20.7275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5786  -21.1310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2817  -19.8935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2802  -20.7197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9957  -21.1305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7091  -20.7163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7072  -19.8913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9917  -19.4805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9894  -18.6555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7027  -18.2410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7004  -17.4160    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.4137  -17.0015    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4833  -16.6125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8750  -17.4125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  7  8  2  0
  3  4  2  0
  8  9  1  0
  4  6  1  0
  9 10  2  0
  5 10  1  0
  5  6  2  0
 10 11  1  0
  1  2  2  0
 11 12  1  0
  5  1  1  0
 12 13  1  0
  2  3  1  0
 13 14  1  0
  6  7  1  0
 13 15  2  0
 13 16  2  0
M  END

Alternative Forms

Associated Targets(Human)

CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 236.30Molecular Weight (Monoisotopic): 236.0619AlogP: 1.13#Rotatable Bonds: 3
Polar Surface Area: 72.19Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.31CX Basic pKa: CX LogP: 0.95CX LogD: 0.95
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.84Np Likeness Score: -1.20

References

1. Parker MH, Smith-Swintosky VL, McComsey DF, Huang Y, Brenneman D, Klein B, Malatynska E, White HS, Milewski ME, Herb M, Finley MF, Liu Y, Lubin ML, Qin N, Iannucci R, Leclercq L, Cuyckens F, Reitz AB, Maryanoff BE..  (2009)  Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies.,  52  (23): [PMID:19388676] [10.1021/jm801432r]

Source